Andrew Boulton (MB, BS, MD, FRCP) graduated with honours in medicine from the University of Newcastle-upon-Tyne in 1976. He subsequently obtained the MRCP (UK) in 1979 and was elected FRCP in 1992. He obtained his MD in the complications of diabetes from the University of Newcastle-upon-Tyne in 1985. After clinical training in Newcastle upon Tyne, Sheffield and later Miami, he was subsequently appointed Professor of Medicine in 1995 with a special interest in diabetes and its complications at the University of Manchester, and Consultant Physician at Manchester Royal Infirmary. His clinical role includes inpatient supervision of patients with diabetic complications and outpatient clinics at the Manchester Diabetes Centre.

His research into diabetic neuropathy and diabetic lower limb problems started more than 40 years ago and he has had grant support over the last few decades from Diabetes UK, EFSD, American Diabetes Association, NIH/NIDDK and others.  He was previously editor of Diabetic Medicine and was senior associate editor for Diabetes Care for 20 years until 2022.  He has published more than 600 peer-reviewed papers.

He is a former Chair of Postgraduate Education, Vice-President and President of the EASD. Until recently (December 2022), he was President of the International Diabetes Federation. His services to international diabetes have been recognised by the award in 2008 of the American Diabetes Association Harold Rifkin Award for distinguished international service in the field of diabetes.

Although part-retired, he still teaches undergraduate and postgraduate students in diabetes and its complications and is a trainer recognised by the GMC.

Duality of Interest: Professor Boulton has received Speaker’s/Honorarium and Board member/ advisory panel fees from AOT Inc.
Date: Spring 2023